{
  "Variants Include": [
    {
      "Gene": "PARK2",
      "variants": [
        {
          "HGVS": "NM_000934.3:c.865G>A",
          "cDNA Change": {
            "transcript": "NM_000934.3",
            "ref": "G",
            "alt": "A",
            "position": "865"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": "289"
          },
          "Description in input context": "c.865G>A (p.G289D)"
        },
        {
          "HGVS": "NM_000934.3:c.868G>A",
          "cDNA Change": {
            "transcript": "NM_000934.3",
            "ref": "G",
            "alt": "A",
            "position": "868"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": "290"
          },
          "Description in input context": "c.868G>A (p.G290D)"
        },
        {
          "HGVS": "NM_000934.3:c.870G>A",
          "cDNA Change": {
            "transcript": "NM_000934.3",
            "ref": "G",
            "alt": "A",
            "position": "870"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": "291"
          },
          "Description in input context": "c.870G>A (p.G291D)"
        },
        {
          "HGVS": "NM_000934.3:c.871G>A",
          "cDNA Change": {
            "transcript": "NM_000934.3",
            "ref": "G",
            "alt": "A",
            "position": "871"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": "292"
          },
          "Description in input context": "c.871G>A (p.G292D)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinsonism",
    "MONDO": "MONDO:0005162"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line/Patients Derived Material",
        "Material Name": "HEK293, patient-derived fibroblasts",
        "Description": "The experiment used HEK293 cells and patient-derived fibroblasts expressing PARK2 variants."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000934.3:c.865G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Protein expression levels were reduced by 30-50% in cells expressing p.G289D."
        },
        {
          "Variant": "NM_000934.3:c.868G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Protein expression levels were reduced by 20-40% in cells expressing p.G290D."
        },
        {
          "Variant": "NM_000934.3:c.870G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Protein expression levels were reduced by 40-60% in cells expressing p.G291D."
        },
        {
          "Variant": "NM_000934.3:c.871G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Protein expression levels were reduced by 50-70% in cells expressing p.G292D."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type PARK2 cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "4"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA with post-hoc Tukey's test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression greater than 80% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression less than 50% of wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Luciferase reporter assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "The experiment used HEK293 cells transiently transfected with PARK2 variants and luciferase reporter plasmids."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000934.3:c.865G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Luciferase activity was increased by 20-30% in cells expressing p.G289D."
        },
        {
          "Variant": "NM_000934.3:c.868G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Luciferase activity was increased by 15-25% in cells expressing p.G290D."
        },
        {
          "Variant": "NM_000934.3:c.870G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Luciferase activity was increased by 25-35% in cells expressing p.G291D."
        },
        {
          "Variant": "NM_000934.3:c.871G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result意图": "Luciferase activity was increased by 30-40% in cells expressing p.G292D."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type PARK2 cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "4"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA with post-hoc Tukey's test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Luciferase activity within 10% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Luciferase activity exceeding 20% of wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunohistochemistry",
      "Material used": {
        "Material Source": "Animal model",
        "Material Name": "PARK2 variant transgenic mice",
        "Description": "The experiment used transgenic mice expressing PARK2 variants for immunohistochemical analysis of brain tissue."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000934.3:c.865G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "increased ubiquitination",
          "Result Description": "Increased ubiquitination of PARK2 protein was observed in transgenic mice expressing p.G289D."
        },
        {
          "Variant": "NM_000934.3:c.868G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "increased ubiquitination",
          "Result Description": "Increased ubiquitination of PARK2 protein was observed in transgenic mice expressing p.G290D."
        },
        {
          "Variant": "NM_000934.3:c.870G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "increased ubiquitination",
          "意图": "Increased ubiquitination of PARK2 protein was observed in transgenic mice expressing p.G291D."
        },
        {
          "Variant": "NM_000934.3:c.871G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "increased ubiquitination",
          "Result Description": "Increased ubiquitination of PARK2 protein was observed in transgenic mice expressing p.G292D."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Five biological replicates were performed for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "No technical replicates were explicitly mentioned."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type PARK2 transgenic mice were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Non-transgenic mice were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "4"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Chi-square test was used for statistical analysis of immunohistochemical staining patterns."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Ubiquitination levels within 15% of wild-type controls.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Ubiquitination levels exceeding 30% of wild-type controls.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}